NEW YORK (GenomeWeb News) – Cellectis bioresearch today announced it has created a US subsidiary.
The US subsidiary is called Cellectis bioresearch Inc., and is headquartered at the Cambridge Innovation Center in Cambridge, Mass. Cellectis bioresearch, based in Romainville, France, is a subsidiary of Cellectis, and provides tools for genome customization.
The US company will be responsible for promoting Cellectis bioresearch products and services in the US. Eric Merle has been named sales director for the US and will be in charge of recruiting and managing a sales staff. He will report to Luc Selig, vice president of sales and marketing at the French operations.